Joseph Leventhal
Medical Director Singulera Therapeutics
Seminars
Wednesday 25th March 2026
Utilizing Tregs to Minimize Immunosuppression Following Transplants
12:00 pm
- Explore how Treg therapies can minimize reliance on broad immunosuppressive drugs, reducing side effects
- Review clinical and translational data supporting Treg use to improve transplant outcomes and long-term graft survival
Wednesday 25th March 2026
Panel Discussion: Evaluating Changing FDA & GMP Expectations to Overcome Regulatory Challenges & Accelerate Clinical Approval
2:30 pm
- Understand how Treg GMP and approval processes have evolved for 2026
- Sharing FDA interactions to reveal and combat manufacturing and regulatory approval challenges
- Identifying opportunities for accelerated regulatory progression amid regulatory changes
